ARDEA BIOSCIENCES, INC./DE Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 31 rows, 31 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-06-19: Reporting owner BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC; Form 4; Security Warrants; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-06-19: Reporting owner BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC; Form 4; Security Warrants; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-06-19: Reporting owner BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC; Form 4; Security Warrants; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-06-19: Reporting owner BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC; Form 4; Security Warrants; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-06-19 | BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Warrants Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −205 0 owned after | $11.14 exercise price | 2012-06-21 | |
| 2012-06-19 | BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Warrants Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −998 0 owned after | $11.14 exercise price | 2012-06-21 | |
| 2012-06-19 | BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Warrants Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −46,195 0 owned after | $11.14 exercise price | 2012-06-21 | |
| 2012-06-19 | BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Warrants Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −147,292 0 owned after | $11.14 exercise price | 2012-06-21 | |
| 2012-06-19 | BAKER JULIAN | BAKER FELIX | BAKER BROS ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Warrants Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,023 0 owned after | $11.14 exercise price | 2012-06-21 | |
| 2012-06-19 | TANG KEVIN C Director, 10% Owner | 4 | Common Stock Warrant (right to buy) Derivative · Indirect · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −39,163 0 owned after | $20.86 | 2012-06-20 | |
| 2012-04-24 holding as of filing | BAKER BROS ADVISORS LLC Director, 10% Owner | 3 | Warrants Derivative · Indirect · See footnotes | Holding | $11.14 exercise price | 2012-04-24 | ||
| 2008-12-19 | BAKER FELIX | Baker Bros. Capital (GP), LLC | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +205 205 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | BAKER JULIAN | Baker Brothers Life Sciences Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +147,292 147,292 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | BAKER JULIAN | BAKER FELIX | 14159 capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +4,023 4,023 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | BAKER JULIAN | Baker Biotech Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +46,195 46,195 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | Baker Biotech Capital (GP), LLC | BAKER FELIX | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +46,195 46,195 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | BAKER FELIX | BAKER JULIAN | Baker / Tisch Capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4/A | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +998 998 owned after | $0.13 | 2008-12-19 | |
| 2008-12-19 | BAKER JULIAN | BAKER FELIX | Baker / Tisch Capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | P Open market or private purchase of non-derivative or derivative security | +998 998 owned after | $0.13 | 2008-12-19 | |
| 2008-12-17 | TANG KEVIN C | TANG CAPITAL MANAGEMENT LLC | TANG CAPITAL PARTNERS LP Director, 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · By LP | P Open market or private purchase of non-derivative or derivative security | +39,163 39,163 owned after | $0.13 | 2008-12-19 | |
| 2008-09-17 | TANG CAPITAL PARTNERS LP | TANG CAPITAL MANAGEMENT LLC | TANG KEVIN C 10% Owner | 10% Owner | Director, 10% Owner | 4 | Common Stock Warrant (Right to Buy) Derivative · Indirect · By LP | X Exercise of in-the-money or at-the-money derivative security | −24,000 0 owned after | $10.85 exercise price | 2008-09-19 | |
| 2007-06-11 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −165,727 0 owned after | $1.03 exercise price | 2007-12-21 | |
| 2007-06-11 | TANG CAPITAL MANAGEMENT LLC | TANG KEVIN C | TANG CAPITAL PARTNERS LP 10% Owner | Director, 10% Owner | 10% Owner | 4 | Common Stock Warrant (Right to Buy) Derivative · Indirect · By LP | X Exercise of in-the-money or at-the-money derivative security | −426,154 0 owned after | $1.03 exercise price | 2007-06-13 | |
| 2007-06-11 | Baker / Tisch Capital (GP), LLC | BAKER JULIAN | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −21,044 0 owned after | $1.03 exercise price | 2007-06-13 | |
| 2007-06-11 | BAKER JULIAN | Baker Bros. Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −28,936 0 owned after | $1.03 exercise price | 2007-06-13 | |
| 2007-06-11 | BAKER FELIX | Baker Biotech Capital (GP), LLC | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −147,313 0 owned after | $1.03 exercise price | 2007-06-13 | |
| 2007-06-11 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER FELIX | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Warrants Derivative · Indirect · Through Partnership | X Exercise of in-the-money or at-the-money derivative security | −165,727 0 owned after | $1.03 exercise price | 2007-06-13 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −147,311 0 owned after | $2.07 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −18,414 0 owned after | $2.07 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | +165,725 165,725 owned after | $2.07 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −30,360 0 owned after | $10.85 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −4,050 0 owned after | $10.85 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | +34,410 34,410 owned after | $2.07 exercise price | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −56 0 owned after | $0.00 | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | −7 0 owned after | $0.00 | 2006-04-28 | |
| 2006-04-25 | Baker Biotech Capital II (GP), LLC | BAKER JULIAN | Baker Biotech Capital III (Z) (GP), LLC | Baker Brothers Life Sciences Capital (GP), LLC | Baker Biotech Capital II (Z) (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Common Stock Warrants (right to buy) Derivative · Indirect · See footnote | J Other acquisition or disposition (describe transaction) | +63 63 owned after | $0.00 | 2006-04-28 |